Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05580770
Title Mirdametinib + BGB-3245 in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors SpringWorks Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Additional content available in CKB BOOST